Liver Transplantation for Hepatocellular Carcinoma at Inonu University

Basit Öğe Kaydı
dc.authoridKahraman, Aysegul Sagir/0000-0002-2147-1181
dc.authoridince, volkan/0000-0002-0714-490X
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridKARAKAS, SERDAR/0000-0001-8314-7806
dc.authoridErsan, Veysel/0000-0002-1510-0288
dc.authorwosidKayaalp, Cuneyt/AAH-1764-2021
dc.authorwosidKahraman, Aysegul Sagir/S-1526-2016
dc.authorwosidince, volkan/M-7325-2017
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidKARAKAS, SERDAR/AAB-3219-2021
dc.authorwosidErsan, Veysel/AAB-9595-2020
dc.contributor.authorKayaalp, Cuneyt
dc.contributor.authorInce, Volkan
dc.contributor.authorErsan, Veysel
dc.contributor.authorKarakas, Serdar
dc.contributor.authorKahraman, Aysegul Sagir
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:43:14Z
dc.date.available2024-08-04T20:43:14Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThere is a great effort in the world to find a new drug in hepatocellular carcinoma (HCC) treatment. Turkey has a limited number of basic science studies to discover a new therapeutic drug for HCC. It seems that Turkey is distanced from the global drug discovery race and competition, however, Turkey has the advantage of a wide experience in living donor liver transplantation, like South Korea and Japan. Turkey can plan new studies on HCC, particularly with living donor liver transplantation. Neoadjuvant treatment methods before living donor liver transplantation for advanced tumors would be a good idea for study in Turkey. Because Inonu University has the busiest liver transplantation program in Turkey, the contribution of Inonu University to trials like this can improve the depth of the studies. To conclude, the Inonu University Liver Transplantation Institute has the busiest program in Turkey with 1,600 transplantations in eight years. The program is based on living donor liver transplantations (80%). Living donor liver transplantation for advanced HCC patients is our favorite topic to study.en_US
dc.identifier.doi10.1007/s12029-017-9965-2
dc.identifier.endpage271en_US
dc.identifier.issn1941-6628
dc.identifier.issn1941-6636
dc.identifier.issue3en_US
dc.identifier.pmid28674912en_US
dc.identifier.scopus2-s2.0-85021845676en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage268en_US
dc.identifier.urihttps://doi.org/10.1007/s12029-017-9965-2
dc.identifier.urihttps://hdl.handle.net/11616/97881
dc.identifier.volume48en_US
dc.identifier.wosWOS:000408772400012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Gastrointestinal Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLiver transplantationen_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectLiving donationen_US
dc.subjectTumor stagingen_US
dc.subjectSurvivalen_US
dc.titleLiver Transplantation for Hepatocellular Carcinoma at Inonu Universityen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu